, Core E The primary goal of the Outreach, Retention and Education Core (OREC) is to identify, recruit, enroll, and retain patients (of certain diagnostic types and racial/ethnic backgrounds) and healthy controls into the Stanford ADRC. We target patients with mild Alzheimer s dementia (AD); amnestic Mild Cognitive Impairment (MCI); mild-to-moderate Parkinson s disease (PD) without MCI or dementia; PD with MCI; dementia with Lewy bodies (DLB) of no greater than mild dementia severity and mild-to-moderate parkinsonism, as well as patients with other disorders as needed to fill specific research needs of the Center; and age-equivalent older adults without cognitive impairment or parkinsonism. We are targeting 20% enrollment of Hispanic/Latino patients from these diagnostic categories over the life of this project. We will begin recruitment of American Indian elders in the third year with their target being 5% of total new enrollment. Fulfillment of this primary aim will be facilitated by use of innovative strategies, in collaboration with academic and community-based partners (e.g., Stanford Geriatric Education Center; Palo Alto Medical Foundation; Alzheimer s Association; American Parkinson Disease Association; and the Indian Health Center of Santa Clara Valley). Our efforts start with the caregiver who will be recruited with the patient, to participate in educational and stress reducing programs that will vary according to diagnosis and /ethnic/linguistic factors. They will be introduced to tools such as Fotonovelas and webnovelas, which are available to assist Hispanic/Latino families to understand the dementias and to deal with caregiver-related stress. In addition, we plan to train Promotoras (indigenous health workers) in case-finding methods and screening for dementia. Additional OREC aims include: to build and strengthen research capacity of our community-based partners; to provide state-of-the-art training to medical students, residents, and Fellows, as well as medical and allied health professionals who work with patients with AD, MCI, PD and other targeted diagnostic categories and families (particularly Hispanic/Latino and American Indian); and to collaborate with other Cores (Admninistrative, Clinical, Neuropathology, and Biostatistics) to further overall Center recruitment and retention goals. Evaluation of our effectiveness at reaching these aims will be guided by a Logic Model approach developed for this Core, which includes measurement of primary, secondary and tertiary outcomes and uses approaches that incorporate both quantitative and qualitative methods. Taken together, these methods and measures will provide rich data for guiding future Core directions. Secondary aims include conducting qualitative research with Hispanic/Latino and American Indian patients and caregivers to understand facilitators and barriers to full participation in the Center, emphasizing culturally - based attitudes towards autopsy/ brain donation and gaining insight to guide future research. In addition, caregiver questionnaire data will be collected to assess depressive symptoms and perceived burden, to understand better how the impact of caregiving may differ across the different groups we are studying.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
1P50AG047366-01A1
Application #
8849315
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2015-07-01
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Kim, Jeehyun; Zhang, Kai; Cai, Weidong et al. (2018) Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications. Neuropsychologia 119:24-33
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Smith, Alexander K; Periyakoil, Vyjeyanthi S (2018) Should We Bury ""The Good Death""? J Am Geriatr Soc 66:856-858
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25

Showing the most recent 10 out of 117 publications